Pulse Biosciences, Inc. Operating Cash Flow
Pulse Biosciences, Inc. (PLSE) reported Operating Cash Flow of -$33.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- Pulse Biosciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$18.71M.
- Pulse Biosciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$14.60M.
- Pulse Biosciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$14.76M.
- Pulse Biosciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$13.04M.
- Pulse Biosciences, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$54.12M.
- Pulse Biosciences, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$36.34M.
- Pulse Biosciences, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$33.04M.
- Pulse Biosciences, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$47.01M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$18.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$33.30M 10-Q · filed 2026-08-06 | -$48.06M derived: sum of 3 quarters · filed 2026-08-06 | -$61.10M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$14.60M 10-Q · filed 2026-05-14 | -$29.35M derived: sum of 2 quarters · filed 2026-05-14 | -$42.39M derived: sum of 3 quarters · filed 2026-05-14 | -$55.20M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$14.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$27.79M derived: sum of 2 quarters · filed 2026-02-19 | -$40.60M derived: sum of 3 quarters · filed 2026-08-06 | -$54.12M 10-K · filed 2026-02-19 |
| 2025-09-30 | -$13.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$25.85M derived: sum of 2 quarters · filed 2026-08-06 | -$39.37M 10-Q · filed 2025-11-05 | -$48.51M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$12.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$26.33M 10-Q · filed 2026-08-06 | -$35.47M derived: sum of 3 quarters · filed 2026-08-06 | -$44.50M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$13.52M 10-Q · filed 2026-05-14 | -$22.66M derived: sum of 2 quarters · filed 2026-05-14 | -$31.69M derived: sum of 3 quarters · filed 2026-05-14 | -$40.08M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$9.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$18.17M derived: sum of 2 quarters · filed 2026-02-19 | -$26.56M derived: sum of 3 quarters · filed 2026-02-19 | -$36.34M 10-K · filed 2026-02-19 |
| 2024-09-30 | -$9.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$17.42M derived: sum of 2 quarters · filed 2025-11-05 | -$27.20M 10-Q · filed 2025-11-05 | -$33.98M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$8.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$18.18M 10-Q · filed 2025-08-12 | -$24.96M derived: sum of 3 quarters · filed 2025-08-12 | -$35.44M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$9.78M 10-Q · filed 2025-05-08 | -$16.56M derived: sum of 2 quarters · filed 2025-05-08 | -$27.05M derived: sum of 3 quarters · filed 2025-05-08 | -$36.25M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$6.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$17.27M derived: sum of 2 quarters · filed 2025-03-31 | -$26.47M derived: sum of 3 quarters · filed 2025-03-31 | -$33.04M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$10.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$19.69M derived: sum of 2 quarters · filed 2024-10-30 | -$26.26M 10-Q · filed 2024-10-30 | -$34.22M derived: sum of 4 quarters · filed 2024-10-30 |
| 2023-06-30 | -$9.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | -$15.77M 10-Q · filed 2024-08-19 | -$23.74M derived: sum of 3 quarters · filed 2024-08-19 | -$34.37M derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | -$6.57M 10-Q · filed 2024-05-07 | -$14.54M derived: sum of 2 quarters · filed 2024-05-07 | -$25.17M derived: sum of 3 quarters · filed 2024-05-07 | -$37.99M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$7.96M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$18.60M derived: sum of 2 quarters · filed 2024-03-28 | -$31.42M derived: sum of 3 quarters · filed 2024-03-28 | -$47.01M 10-K · filed 2024-03-28 |
| 2022-09-30 | -$10.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$23.45M derived: sum of 2 quarters · filed 2023-11-13 | -$39.05M 10-Q · filed 2023-11-13 | -$51.74M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$12.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$28.42M 10-Q · filed 2023-08-10 | -$41.11M derived: sum of 3 quarters · filed 2023-08-10 | -$54.46M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$15.59M 10-Q · filed 2023-05-11 | -$28.29M derived: sum of 2 quarters · filed 2023-05-11 | -$41.64M derived: sum of 3 quarters · filed 2023-05-11 | -$58.00M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$12.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$26.04M derived: sum of 2 quarters · filed 2023-03-31 | -$42.41M derived: sum of 3 quarters · filed 2023-03-31 | -$54.10M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$13.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$29.72M derived: sum of 2 quarters · filed 2022-11-10 | -$41.40M 10-Q · filed 2022-11-10 | -$50.66M derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-06-30 | -$16.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$28.05M 10-Q · filed 2022-08-10 | -$37.31M derived: sum of 3 quarters · filed 2023-03-31 | -$45.86M derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-03-31 | -$11.69M 10-Q · filed 2022-05-11 | -$20.94M derived: sum of 2 quarters · filed 2023-03-31 | -$29.49M derived: sum of 3 quarters · filed 2023-03-31 | -$37.43M derived: sum of 4 quarters · filed 2023-03-31 |
| 2020-12-31 | -$9.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$17.80M derived: sum of 2 quarters · filed 2023-03-31 | -$25.74M derived: sum of 3 quarters · filed 2023-03-31 | -$35.37M 10-K · filed 2023-03-31 |
| 2020-09-30 | -$8.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$16.49M derived: sum of 2 quarters · filed 2021-11-15 | -$26.11M 10-Q · filed 2021-11-15 | -$35.31M derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-06-30 | -$7.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$17.56M 10-Q · filed 2021-08-09 | -$26.76M derived: sum of 3 quarters · filed 2022-03-31 | -$34.72M derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-03-31 | -$9.62M 10-Q · filed 2021-05-10 | -$18.82M derived: sum of 2 quarters · filed 2022-03-31 | -$26.78M derived: sum of 3 quarters · filed 2022-03-31 | -$36.48M derived: sum of 4 quarters · filed 2022-03-31 |
| 2019-12-31 | -$9.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$17.16M derived: sum of 2 quarters · filed 2022-03-31 | -$26.86M derived: sum of 3 quarters · filed 2022-03-31 | -$34.19M 10-K · filed 2022-03-31 |
| 2019-09-30 | -$7.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$17.66M derived: sum of 2 quarters · filed 2020-11-09 | -$24.99M 10-Q · filed 2020-11-09 | -$31.30M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | -$9.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$17.02M 10-Q · filed 2020-08-10 | -$23.33M derived: sum of 3 quarters · filed 2021-03-12 | -$30.18M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | -$7.33M 10-Q · filed 2020-05-11 | -$13.64M derived: sum of 2 quarters · filed 2021-03-12 | -$20.49M derived: sum of 3 quarters · filed 2021-03-12 | -$26.21M derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | -$6.31M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$13.16M derived: sum of 2 quarters · filed 2021-03-12 | -$18.88M derived: sum of 3 quarters · filed 2021-03-12 | -$23.90M 10-K · filed 2021-03-12 |
| 2018-09-30 | -$6.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$12.57M derived: sum of 2 quarters · filed 2019-11-07 | -$17.59M 10-Q · filed 2019-11-07 | -$21.55M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | -$5.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$10.74M 10-Q · filed 2019-08-08 | -$14.70M derived: sum of 3 quarters · filed 2020-03-16 | -$18.12M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-03-31 | -$5.02M 10-Q · filed 2019-05-03 | -$8.98M derived: sum of 2 quarters · filed 2020-03-16 | -$12.40M derived: sum of 3 quarters · filed 2020-03-16 | -$13.61M derived: sum of 4 quarters · filed 2020-03-16 |
| 2017-12-31 | -$3.96M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$7.38M derived: sum of 2 quarters · filed 2020-03-16 | -$8.59M derived: sum of 3 quarters · filed 2020-03-16 | -$11.09M 10-K · filed 2020-03-16 |
| 2017-09-30 | -$3.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$4.63M derived: sum of 2 quarters · filed 2018-11-01 | -$7.12M 10-Q · filed 2018-11-01 | |
| 2017-06-30 | -$1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | -$3.71M 10-Q · filed 2018-07-31 | ||
| 2017-03-31 | -$2.50M 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | -$8.05M 10-K · filed 2019-03-14 | |||
| 2015-12-31 | -$3.32M 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |